Best Wearable Migraine Device in 2026

Migraine is a common neurological disease. In the U.S., it affects up to 17% of women and 6% of men. Globally, migraine is the second-leading cause of disability.  Wearable and handheld neuromodulation devices offer a drug-free approach, using targeted electrical or magnetic pulses to interact with nerve pathways involved in migraine.

The Cefaly device stands out because it combines FDA-cleared acute and preventive migraine treatment, external trigeminal nerve stimulation, at-home use, app support where available, and prescription-free access in the U.S., Canada, the EU, and other countries. The broader migraine-device landscape now includes several FDA-cleared options with different nerve targets, treatment formats, and access requirements. 

Key Takeaways

• Drug-free options exist for both acute migraine treatment and long-term prevention through FDA-cleared neuromodulation devices
• Cefaly is available without a prescription in the U.S., Canada, the EU, and other countries
• Different devices target different nerves, including the trigeminal nerve, vagus nerve, occipital nerves, and peripheral nerves
• Cefaly’s documented side effects are generally minor and reversible, including sleepiness during use, post-session headache, forehead redness, mild nausea, or rare skin allergy
• Companion apps can support treatment tracking, migraine logging, and pattern awareness over time

Understanding Wearable Migraine Technology: What Is e-TNS?

Wearable migraine devices work through neuromodulation, delivering targeted electrical or magnetic impulses to specific nerve pathways involved in migraine. The technology varies by device, but the general goal is to influence nerve signaling associated with migraine symptoms.

How External Trigeminal Nerve Stimulation Targets Migraine Pain

External trigeminal nerve stimulation (e-TNS) is a device-based approach used in wearable migraine treatment. The trigeminal nerve is a major pathway involved in migraine pain, with branches across the face and forehead. When this nerve pathway is active during a migraine attack, it can transmit pain signals that contribute to migraine symptoms.

e-TNS devices deliver precise electrical impulses through an electrode positioned on the forehead, between and just above the eyebrows. Cefaly uses this approach to target the trigeminal nerve with a 60-minute Acute program and a 20-minute daily Prevent program.

The Science Behind Wearable Migraine Relief

Different devices target different nerve pathways:

• Trigeminal nerve stimulation: Uses a forehead placement to target the trigeminal nerve pathway
• Vagus nerve stimulation: Uses a neck placement to stimulate the vagus nerve
• Remote electrical neuromodulation: Uses an upper-arm placement to deliver peripheral nerve stimulation
• Transcranial magnetic stimulation: Uses magnetic pulses held near the back of the head

Each device has its own FDA-cleared indication, treatment format, and placement.

1) Cefaly

Best For: Adults comparing a prescription-free, forehead-based migraine device for both acute and preventive treatment

Access: Available without a prescription in the U.S., Canada, the EU, and other countries

Treatment Format: External trigeminal nerve stimulation device with a 60-minute Acute program and a 20-minute daily Prevent program

Cefaly uses external trigeminal nerve stimulation through an electrode placed on the forehead, between and just above the eyebrows. This format is designed to target the trigeminal nerve pathway using a non-invasive, drug-free device that can be used at home.

What Makes It Stand Out

Cefaly offers prescription-free access, both acute and preventive treatment formats, forehead-based e-TNS technology, app support where available, HSA/FSA eligibility, optional electrode subscription, coaching support where available, and a 90-calendar-day satisfaction guarantee for direct purchases.

2) Nerivio

Best For: People comparing an upper-arm device format and prescription-based access

Access: Prescription required

Treatment Format: Smartphone-controlled remote electrical neuromodulation device worn on the upper arm

Nerivio uses remote electrical neuromodulation through an upper-arm wearable. This format differs from forehead-based devices because the device is worn away from the head, which may be an important practical consideration for people comparing device placement during migraine attacks.

What Makes It Stand Out

Nerivio offers upper-arm placement, smartphone-controlled treatment, and an FDA-cleared age indication for ages 8 and older. It is generally discussed as a prescription device for acute and preventive migraine treatment, depending on the applicable indication and prescribing context.

3) gammaCore

Best For: People comparing a handheld neck-placement device and prescription-based access

Access: Prescription required

Treatment Format: Handheld non-invasive vagus nerve stimulation device placed on the neck

gammaCore uses non-invasive vagus nerve stimulation through a handheld device placed on the neck. This format differs from forehead-based and upper-arm devices because it targets the vagus nerve rather than the trigeminal nerve or peripheral nerves in the arm.

What Makes It Stand Out

gammaCore offers a handheld format, neck-based placement, and non-invasive vagus nerve stimulation. It is generally discussed as a prescription device used in migraine and cluster headache care, depending on the applicable indication and prescribing context.

4) SAVI Dual

Best For: People comparing a pulse-based magnetic stimulation device and prescription-based access

Access: Prescription required

Treatment Format: Portable single-pulse transcranial magnetic stimulation device held to the back of the head

SAVI Dual provides pulse-based magnetic stimulation. It uses magnetic pulses rather than electrical nerve stimulation.

What Makes It Stand Out

SAVI Dual offers a non-invasive magnetic stimulation format, back-of-head placement, and acute and preventive treatment positioning. It is generally discussed as a prescription device for patients 12 and older, depending on the applicable indication and prescribing context.

5) Relivion MG

Best For: People comparing a head-worn device that uses both trigeminal and occipital nerve stimulation

Access: Prescription required

Treatment Format: Head-worn neuromodulation device that stimulates trigeminal and occipital nerve branches

Relivion MG uses a headband-style format that stimulates nerve branches associated with both the trigeminal and occipital nerves. This format differs from single-placement devices because it is worn around the head and is designed to target multiple nerve branches at the same time.

What Makes It Stand Out

Relivion MG offers a head-worn device format, simultaneous trigeminal and occipital nerve stimulation, and app-connected treatment support. It is generally discussed as a prescription device for acute migraine treatment in adults, depending on the applicable indication and prescribing context.

6) HeadaTerm 2

Best For: People comparing a lower-cost, forehead-based e-TNS device with over-the-counter access

Access: Available without a prescription

Treatment Format: Forehead-worn external trigeminal nerve stimulation device

HeadaTerm 2 uses forehead-based external trigeminal nerve stimulation. This format is similar in placement category to other forehead e-TNS devices, but it is generally positioned around lower upfront cost, rechargeable use, and over-the-counter access.

What Makes It Stand Out

HeadaTerm 2 offers forehead placement, e-TNS technology, rechargeable use, manual intensity adjustment, and non-prescription access.

Why Cefaly Stands Out

Among FDA-cleared wearable migraine devices, Cefaly offers distinct advantages:

• Pioneer status: First device to receive FDA clearance for migraine prevention in 2014 and later cleared for acute treatment in 2017
• No prescription required: Available without a prescription in the U.S., Canada, the EU, and other countries
• Dual-mode treatment: Both 20-minute preventive and 60-minute acute options in one device
• Cefaly clinical evidence: More than 20 years of research and 12 clinical trials support Cefaly’s acute and preventive migraine treatment data
• Support ecosystem: App support where available, optional electrode subscription, free one-on-one coaching where available, HSA/FSA eligibility, and a 90-calendar-day satisfaction guarantee for direct purchases

The Cefaly device targets the trigeminal nerve through an electrode positioned on the forehead, between and just above the eyebrows. For adults seeking a prescription-free, drug-free, non-invasive migraine device with both acute and preventive treatment formats, Cefaly combines accessible purchase options. 

Frequently Asked Questions

How does a wearable migraine device like Cefaly work?

Cefaly uses external trigeminal nerve stimulation (e-TNS) to deliver precise electrical impulses through an electrode placed on the forehead, between and just above the eyebrows. The trigeminal nerve is a major pathway involved in migraine pain. Cefaly includes a 60-minute Acute mode for use during a migraine attack and a 20-minute daily Prevent mode for preventive treatment.

Can a wearable device really prevent migraines, or only treat them?

Some FDA-cleared migraine devices are designed for acute treatment, preventive treatment, or both. Cefaly offers both a 60-minute Acute program and a 20-minute daily Prevent program. The PREMICE study demonstrated that Cefaly users experienced a 32.7% decrease in monthly headache days after three months of compliant preventive treatment.

Are there any serious side effects associated with Cefaly?

Multiple clinical studies have demonstrated that there are no serious adverse effects associated with Cefaly treatment. Cefaly’s documented adverse effects are minor and fully reversible upon stopping device use. Documented side effects include sleepiness during use, post-session headache, forehead skin redness, mild nausea, and rare forehead skin allergy.

How often is Cefaly used for acute and preventive treatment?

Cefaly’s Acute mode is a 60-minute session designed for use during a migraine attack. Cefaly’s Prevent mode is a 20-minute daily session designed for preventive treatment. Clinical trials show meaningful reductions in migraine frequency after three months of consistent preventive use.

Is a prescription required to purchase the best wearable migraine device?

Cefaly is available without a prescription in the U.S., Canada, the EU, and other countries. HeadaTerm 2 also does not require a prescription. Other devices, including Nerivio, gammaCore, SAVI Dual, and Relivion MG, require a prescription from a healthcare provider. The certified provider network includes neurologists, headache specialists, and other practitioners who can discuss whether a device is appropriate for your situation.